APA
Hellwig S., Kreft A., Amtage F., Tüscher O., Winz O. H., Hellwig B., Weiller C., Weber W. A., Vach W. & Meyer P. T. (20140204). 123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Chicago
Hellwig Sabine, Kreft Annabelle, Amtage Florian, Tüscher Oliver, Winz Oliver H, Hellwig Bernhard, Weiller Cornelius, Weber Wolfgang A, Vach Werner and Meyer Philipp T. 20140204. 123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Harvard
Hellwig S., Kreft A., Amtage F., Tüscher O., Winz O. H., Hellwig B., Weiller C., Weber W. A., Vach W. and Meyer P. T. (20140204). 123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
MLA
Hellwig Sabine, Kreft Annabelle, Amtage Florian, Tüscher Oliver, Winz Oliver H, Hellwig Bernhard, Weiller Cornelius, Weber Wolfgang A, Vach Werner and Meyer Philipp T. 123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 20140204.